17 hours Pfizer: No More Growth – Still A Worthy Dividend Buy Seeking Alpha

   X     

2 days Pfizer: Investors Won’t Stick Around Forever Seeking Alpha

   X     

2 days Ozempic, Wegovy shortage resolved; Pfizer CEO is PhRMA’s new chair Yahoo Finance

   X     

2 days Pfizer ends global development of Beqvez gene therapy Investing.com

   X     

4 days Why Pfizer’s Stock Price Isn’t Reflecting Its True Value Seeking Alpha

   X     

4 days Pfizer Stock’s Upside Got Bigger Seeking Alpha

   X     

4 days Pfizer CEO Albert Bourla: Focusing on opportunities outside of vaccines with RFK Jr. YouTube

   X     

6 days Pfizer: Danuglipron Could Tip The Scale In A Few Years, But For Now, Sell Seeking Alpha

   X     

2 weeks Pfizer: 3 Key Risks That Warrant A Sell Seeking Alpha

   X     

2 weeks Sangamo Therapeutics: Challenging Road Ahead After Pfizer Exit Seeking Alpha

   X     

2 weeks Pfizer: Challenges Loom Amid Overvaluation Seeking Alpha

   X     

2 weeks Fighting Cancer Becomes Top Priority for Pfizer YouTube

   X     

2 weeks Pfizer’s cancer frontier #shorts #wallstreetweek #pfizer YouTube

   X     

2 weeks The faulty forecasts of pharma firm investors: Misguided cynics miss the promising prognosis for drugmakers Pfizer and Merck Fortune

   X     

3 weeks Pfizer, Inc. (PFE) Q4 2024 Earnings Call Transcript Seeking Alpha

   X     

3 weeks Pfizer Q4 Earnings: Solid Results, But Guidance And Patent Concerns Drive The Stock Down Seeking Alpha

   X     

3 weeks Pfizer (PFE) Q4 2024 Earnings Call Transcript Yahoo Finance

   X     

3 weeks Pfizer’s Q4 Earnings Beat Estimates, Non-Covid Drugs Drive Sales Zacks

   X     

3 weeks Pfizer shows profit growth from cost cuts and steadier COVID sales Investing.com

   X     

3 weeks Pre-Markets Flat Ahead of JOLTS; Q4 Earnings for PFE, PYPL, PEP & More Zacks

   X     

3 weeks Pfizer beats Q4, FY ’24 earnings estimates, stock flat in early trading Yahoo Finance

   X     

3 weeks Compared to Estimates, Pfizer (PFE) Q4 Earnings: A Look at Key Metrics Zacks

   X     

3 weeks PFE’s Colorectal Cancer Drug Meets Other Dual Primary Goal of PFS Zacks

   X     

3 weeks Pfizer Q4 Earnings: Revenue And EPS Beat, Seagen And COVID-19 Products Show Strength, Issues Strong FY25 Outlook Yahoo Finance

   X     

3 weeks Pfizer’s Covid Products Drove Its Fourth-Quarter Upside. But Is It Sustainable? Investor's Business Daily

   X     

3 weeks Pfizer beats Q4, FY ’24 earnings estimates, stock down slightly in premarket trading Yahoo Finance

   X     

3 weeks Mizuho’s Jared Holz on Merck and Pfizer Q4 results, 2025 outlook for Big Pharma stocks YouTube

   X     

3 weeks Pfizer’s stock falls despite fourth-quarter revenue and earnings beat. This analyst expects growth to accelerate. MarketWatch

   X     

3 weeks Pfizer (PFE) Beats Q4 Earnings and Revenue Estimates Zacks

   X     

3 weeks Pfizer Falls on RFK’s Progress Towards Confirmation Despite Good Earnings. Its CEO is Unbothered. Yahoo Finance

   X     

3 weeks Pfizer beats profit estimates on heart disease drug, COVID vaccine sales Investing.com

   X     

3 weeks The Zacks Analyst Blog Highlights Merck, Pfizer, Eli Lilly, Amgen and Bristol Myers Squibb Zacks

   X     

3 weeks Will These 5 Big Drug Stocks Surpass Q4 Earnings Forecasts? Zacks

   X     

3 weeks Will Non-COVID Drugs Drive PFE’s Top Line in Q4 Earnings? Zacks

   X     

3 weeks Smaller US winter COVID wave adds pressure to Pfizer turnaround Investing.com

   X     

3 weeks Smaller US winter COVID wave adds pressure to Pfizer turnaround Yahoo Finance

   X     

3 weeks Major players in the anti-DEI movement: Here’s who’s attacking Goldman Sachs, Pfizer, IBM, and other Fortune 500 companies Fortune

   X     

3 weeks Pfizer resolves conservative challenge to diversity fellowship program Investing.com

   X     

3 weeks Investors Heavily Search Pfizer Inc. (PFE): Here is What You Need to Know Zacks

   X     

3 weeks Pfizer (PFE) is a Top-Ranked Momentum Stock: Should You Buy? Zacks

   X     

3 weeks Exploring Analyst Estimates for Pfizer (PFE) Q4 Earnings, Beyond Revenue and EPS Zacks

   X     

4 weeks Pfizer Q4 Earnings Preview: 5 Critical Business Issues To Consider Seeking Alpha

   X     

4 weeks PFE Stock Rises on Reports of Averting Proxy Fight With Activist Investor Zacks

   X     

4 weeks Here’s How to Play Pfizer Stock Before Q4 Earnings Release Zacks

   X     

4 weeks Pfizer Jumps After Avoiding Proxy Fight With Activist Investor Starboard — For Now Investor's Business Daily

   X     

4 weeks Pfizer to pay $59.7 million over kickbacks for migraine drug Investing.com

   X     

1 month Here’s Why Pfizer (PFE) is a Strong Value Stock Zacks

   X     

1 month Why Pfizer (PFE) Outpaced the Stock Market Today Zacks

   X     

1 month Pfizer CEO: Americans can expect radical change from this upcoming Trump administration YouTube

   X     

1 month Here is What to Know Beyond Why Pfizer Inc. (PFE) is a Trending Stock Zacks

   X